查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
止血阀市场预测到 2028 年-按类型（单手止血阀、双 Y 连接器止血阀、止血阀 Y 连接器、其他类型）、按应用、按最终用户、按地区分类的全球分析
市场调查报告书
商品编码
1273564

止血阀市场预测到 2028 年-按类型（单手止血阀、双 Y 连接器止血阀、止血阀 Y 连接器、其他类型）、按应用、按最终用户、按地区分类的全球分析

Hemostasis Valve Market Forecasts to 2028 - Global Analysis By Type (One-handed Hemostasis Valves, Double Y-connector Hemostasis Valves, Hemostasis Valve Y-connectors and Other Types), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2022 年全球止血阀市场规模将达到 1722 亿美元，预计到 2028 年将达到 2556 亿美元，预测期内復合年增长率为 6.8%。成长。

止血阀组用于在手术过程中连接或引入导管和导丝。 当介入装置被放置在人体循环系统中时，止血阀旨在用作导管。 止血阀常用于神经血管内手术，以降低血栓形成的风险。 新的止血阀也正在开发中，旨在最大限度地减少出血。

根据世界卫生组织 (WHO) 的数据，心血管疾病每年导致约 1790 万人死亡，成为全球第一大死因。

市场动态

驱动程序

心血管疾病患病率上升

止血阀常用于心血管手术，以阻止失血并减少潜在问题。 被称为心血管疾病的疾病是那些损害心臟和血液动脉的疾病。 通过帮助外科医生控制出血和减少并发症，止血阀在这些手术中是必不可少的。 心血管疾病患病率的增加是市场的主要驱动力之一。

约束

低能见度：

普通大众对止血阀的了解非常少。 缺乏关于这些小工具的知识。 止血阀的可用性是有限的。 止血阀安装在体内以控制出血。 瓣膜内血凝块的发展是一种被称为瓣膜病的可能性。 此外，技术问题和止血阀导致空气栓塞的可能性预计将抑制市场扩张。

机会

微创手术需求扩大

在手术过程中减少切口称为微创手术。 由于其优于传统程序，这些程序正变得越来越流行。 该瓣膜对于手术至关重要，因为它在微创手术中起到控制出血的作用。 因此，越来越多地使用微创手术是市场扩张的推动力。

威胁

止血阀成本高

金属、聚合物和陶瓷只是用于製造止血阀的部分材料。 製造过程复杂且这些材料昂贵。 因此，止血阀价格昂贵。 市场上的一大问题是止血阀的价格。 然而，止血阀的高价格和合格医师的短缺限制了市场的扩张。

COVID-19 的影响：

随着越来越多的人感染 COVID-19，可用的控制设备激增。 儘管设备种类繁多，但雾化器、氧气发生器、生命支持设备和监护仪等呼吸支持设备是重症临床护理中最常用的医疗设备。 手套、口罩和护目镜只是可能因大流行而被用作个人防护设备的医疗产品的几个例子。 医疗专业人员和公众都注意到用于预防的此类设备和个人防护设备的增加。

预计在预测期内止血阀 Y 型连接器部分将是最大的部分

随着止血阀 Y 型连接器在各种医疗程序中的应用越来越多，预计该领域将实现有利可图的增长。 Y 型连接器在导管插入过程中提供可靠的密封。 它也非常易于使用，几乎不需要对医务人员进行培训。 此外，止血阀的创新使更好的设计成为可能，从而提供更高的疗效和更低的感染风险。

预计在预测期内，医院行业的复合年增长率最高

由于心血管疾病患病率的增加，预计在预测期内，医院部门将以最快的复合年增长率增长。 这部分是因为随着发展中国家基础设施建设的进步，希望在医院接受手术的患者数量增加，导致医院数量增加。 包括健康饮食、支持服务、良好环境和患者安全在内的基础设施将在增加对医院的需求方面发挥关键作用。

份额最大的地区

由于心血管疾病患病率上升，亚太地区预计在预测期内将占据最大的市场份额。 不断上升的医疗保健成本和对微创手术的需求增加也在增加市场价值。 区域投资也是由于该领域领导者的兴趣和支出增加，以及正在进行的合作项目。 此外，医院数量的扩大和医疗旅游也是影响该地区发展的因素。

复合年增长率最高的地区：

预计欧洲在预测期内的复合年增长率最高。 这是由于癌症患病率上升以及医疗保健部门的战略政策和投资所致。 在此背景下，心血管疾病的发病率不断上升，而患者偏爱微创手术。 该地区的增长是由老年人口增加、介入手术需求和健康意识等原因推动的。

主要发展：

2020 年 12 月，全球领先的医疗保健产品和服务提供商 Teleflex, Inc. 宣布完成其宣布的对该行业止血产品製造商 Z-Medica, LLC 的收购。做到了。

2020 年 11 月，Freudenberg Medical 最近在马萨诸塞州建立了全球总部，并在马萨诸塞州贝弗利建立了一个新的医疗生产设施。

这份报告提供了什么

  • 区域和国家级细分市场的市场份额评估
  • 向新进入者提出战略建议
  • 2020、2021、2022、2025 和 2028 年的综合市场数据
  • 市场驱动因素（市场趋势、制约因素、机遇、威胁、挑战、投资机会、建议）。
  • 根据市场预测在关键业务领域提出战略建议
  • 竞争格局映射关键共同趋势。
  • 公司简介，包括详细的战略、财务状况和近期发展
  • 映射最新技术进步的供应链趋势

免费定制优惠：

订阅此报告的客户将获得以下免费定制选项之一。

  • 公司简介
    • 其他市场参与者的综合概况（最多 3 家公司）
    • 主要参与者的 SWOT 分析（最多 3 家公司）
  • 区域细分
    • 根据客户的要求对主要国家/地区的市场估计/预测/复合年增长率（注意：基于可行性检查）。
  • 竞争基准
    • 根据产品组合、区域影响力和战略联盟对主要参与者进行基准测试

内容

第 1 章执行摘要

第二章前言

  • 概览
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 调查来源
    • 主要研究来源
    • 二级研究来源
    • 假设

第三章市场趋势分析

  • 司机
  • 约束因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第 5 章全球止血阀市场：按类型

  • 单手止血阀
  • 双Y接头止血阀
  • 止血阀 Y 型连接器
  • 其他类型

第 6 章全球止血阀市场：按应用

  • 血管成形术
  • 血管造影
  • 介入心脏病学和放射学
  • 其他用途

第 7 章全球止血阀市场：按最终用户分类

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他最终用户

第 8 章全球止血阀市场：区域

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东和非洲地区

第九章主要进展

  • 合同、伙伴关係、协作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章公司简介

  • Terumo Corporation
  • Freudenberg Medical
  • Boston Scientific Corporation
  • Merit Medical Systems
  • Teleflex Incorporated
  • B. Braun Melsungen
  • Argon Medical
  • DeRoyal Industries
  • Abbott Laboratories
  • Argon Medical Devices
  • Excel Medical Products
  • Qosina Corporation
  • Scitech
Product Code: SMRC22861

According to Stratistics MRC, the Global Hemostasis Valve Market is accounted for $172.2 billion in 2022 and is expected to reach $255.6 billion by 2028 growing at a CAGR of 6.8% during the forecast period. Hemostasis valve sets are used to connect or introduce catheters and guide wires during surgery. When interventional devices are placed into the human circulatory system, hemostasis valve is intended to be employed as a conduit. In neuroendovascular surgeries, a hemostasis valve is typically employed to lower the risk of thrombosis. A new hemostasis valve that is intended to minimise blood loss has also been developed.

According to the World Health Organization (WHO), CVDs are responsible for approximately 17.9 million deaths each year, making them the leading cause of death globally.

Market Dynamics:

Driver:

Rise in prevalence of cardiovascular diseases

Hemostasis valves are frequently employed during cardiovascular procedures to stop blood loss and lessen the possibility of problems. A category of conditions known as cardiovascular illnesses damage the heart and blood arteries. By assisting surgeons in controlling bleeding and reducing complications, hemostasis valves are essential in these operations. Increase in prevalence of cardiovascular diseases is one of the key drivers of the market.

Restraint:

Lack of awareness:

The general population has little knowledge of hemostasis valves. There is a shortage of knowledge on these gadgets. The availability of hemostasis valves is limited. The body is fitted with hemostasis valves to regulate bleeding. A blood clot developing in the valve is a possibility known as valve thrombosis. Additionally, it is anticipated that technical issues and the potential for air embolism caused by the hemostasis valve may restrain market expansion.

Opportunity:

Growth in demand for minimally invasive surgeries

Smaller incisions during surgery are referred to as minimally invasive techniques. Due to the advantages these procedures provide over more conventional procedures, they are becoming more and more popular. Due to its role in regulating bleeding during minimally invasive surgeries, this valve is a crucial part of those operations. Therefore, a rise in the use of less invasive procedures is driving market expansion.

Threat:

High Cost of Hemostasis Valves

Metals, polymers, and ceramics are just a few of the materials used to make hemostasis valves. The production process is intricate, and these materials are pricey. Hemostasis valves are hence costly. One of the biggest issues facing the market is the price of hemostasis valves. The expensive price of hemostasis valves and the scarcity of qualified doctors, however, are limiting market expansion.

COVID-19 Impact:

Numerous people are becoming infected with COVID-19, which has led to a sharp increase in the amount of available management equipment. There are many different equipment, but respiratory support devices such atomizers, oxygen generators, life support machines, and monitors are among the most commonly utilised medical devices in critical clinical treatment. Gloves, masks, and protective eyewear are just a few of the medical products that might be employed as personal protection equipment as a result of the pandemic. Both medical experts and the general public have noticed an increase in such devices and personal protection equipment as preventative measures.

The hemostasis valve y-connectors segment is expected to be the largest during the forecast period

The hemostasis valve y-connectors segment is estimated to have a lucrative growth, due to they are increasingly used in various medical procedures. Y-connectors give catheterization procedures a reliable seal. They are very simple to use and require little training for medical personnel. Furthermore, superior designs that offer greater efficacy and a lower risk of infection have been made possible by technological breakthroughs in hemostasis valves.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increase in prevalence of cardiovascular diseases. This is partly because there are more hospitals in developing nations as a result of initiatives for infrastructure construction and a rise in the number of patients who want to have surgery in a hospital. Infrastructures including wholesome food, support services, a positive environment, and patient safety will play a significant role in raising demand for hospitals.

Region with Largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rise in prevalence of cardiovascular diseases. The market value is also being boosted by rising healthcare costs and an increase in demand for minimally invasive surgeries. Regional investment is also due to growing sector leaders' interest and spending as well as continuous collaborative projects. Additionally, expanding hospital numbers and medical tourism are some of the elements influencing the development of the regional sector.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to the elevated prevalence of cancer coupled with strategic policies and investment in the healthcare sector. This is brought on by the rising incidence of cardiovascular disorders and patients' choice for minimally invasive procedures. The region's growth is being fueled by reasons such as an increase in senior population, interventional surgery demand, and health awareness.

Key players in the market:

Some of the key players profiled in the Hemostasis Valve Market include: Terumo Corporation, Freudenberg Medical, Boston Scientific Corporation, Merit Medical Systems, Teleflex Incorporated, B. Braun Melsungen, Argon Medical, DeRoyal Industries, Abbott Laboratories , Argon Medical Devices, Excel Medical Products, Qosina Corporation and Scitech.

Key Developments:

In December 2020, Teleflex Incorporated, a leading global provider of health - care items and services, announced that it has completed the announced acquisition of Z-Medica, LLC, a sector manufacturing company of hemostatic products.

In November 2020, Freudenberg Medical recently built its worldwide headquarters in Massachusetts and its new medical production facility in Beverly, Massachusetts.

Types Covered:

  • One-handed Hemostasis Valves
  • Double Y-connector Hemostasis Valves
  • Hemostasis Valve Y-connectors
  • Other Types

Applications Covered:

  • Angioplasty
  • Angiography
  • Interventional Cardiology & Radiology
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Hemostasis Valve Market, By Type

  • 5.1 Introduction
  • 5.2 One-handed Hemostasis Valves
  • 5.3 Double Y-connector Hemostasis Valves
  • 5.4 Hemostasis Valve Y-connectors
  • 5.5 Other Types

6 Global Hemostasis Valve Market, By Application

  • 6.1 Introduction
  • 6.2 Angioplasty
  • 6.3 Angiography
  • 6.4 Interventional Cardiology & Radiology
  • 6.5 Other Applications

7 Global Hemostasis Valve Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgery Centers
  • 7.4 Specialty Clinics
  • 7.5 Other End Users

8 Global Hemostasis Valve Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Terumo Corporation
  • 10.2 Freudenberg Medical
  • 10.3 Boston Scientific Corporation
  • 10.4 Merit Medical Systems
  • 10.5 Teleflex Incorporated
  • 10.6 B. Braun Melsungen
  • 10.7 Argon Medical
  • 10.8 DeRoyal Industries
  • 10.9 Abbott Laboratories
  • 10.10 Argon Medical Devices
  • 10.11 Excel Medical Products
  • 10.12 Qosina Corporation
  • 10.13 Scitech

List of Tables

  • Table 1 Global Hemostasis Valve Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Hemostasis Valve Market Outlook, By Type (2020-2028) ($MN)
  • Table 3 Global Hemostasis Valve Market Outlook, By One-handed Hemostasis Valves (2020-2028) ($MN)
  • Table 4 Global Hemostasis Valve Market Outlook, By Double Y-connector Hemostasis Valves (2020-2028) ($MN)
  • Table 5 Global Hemostasis Valve Market Outlook, By Hemostasis Valve Y-connectors (2020-2028) ($MN)
  • Table 6 Global Hemostasis Valve Market Outlook, By Other Types (2020-2028) ($MN)
  • Table 7 Global Hemostasis Valve Market Outlook, By Application (2020-2028) ($MN)
  • Table 8 Global Hemostasis Valve Market Outlook, By Angioplasty (2020-2028) ($MN)
  • Table 9 Global Hemostasis Valve Market Outlook, By Angiography (2020-2028) ($MN)
  • Table 10 Global Hemostasis Valve Market Outlook, By Interventional Cardiology & Radiology (2020-2028) ($MN)
  • Table 11 Global Hemostasis Valve Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 12 Global Hemostasis Valve Market Outlook, By End User (2020-2028) ($MN)
  • Table 13 Global Hemostasis Valve Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 14 Global Hemostasis Valve Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 15 Global Hemostasis Valve Market Outlook, By Specialty Clinics (2020-2028) ($MN)
  • Table 16 Global Hemostasis Valve Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 17 North America Hemostasis Valve Market Outlook, By Country (2020-2028) ($MN)
  • Table 18 North America Hemostasis Valve Market Outlook, By Type (2020-2028) ($MN)
  • Table 19 North America Hemostasis Valve Market Outlook, By One-handed Hemostasis Valves (2020-2028) ($MN)
  • Table 20 North America Hemostasis Valve Market Outlook, By Double Y-connector Hemostasis Valves (2020-2028) ($MN)
  • Table 21 North America Hemostasis Valve Market Outlook, By Hemostasis Valve Y-connectors (2020-2028) ($MN)
  • Table 22 North America Hemostasis Valve Market Outlook, By Other Types (2020-2028) ($MN)
  • Table 23 North America Hemostasis Valve Market Outlook, By Application (2020-2028) ($MN)
  • Table 24 North America Hemostasis Valve Market Outlook, By Angioplasty (2020-2028) ($MN)
  • Table 25 North America Hemostasis Valve Market Outlook, By Angiography (2020-2028) ($MN)
  • Table 26 North America Hemostasis Valve Market Outlook, By Interventional Cardiology & Radiology (2020-2028) ($MN)
  • Table 27 North America Hemostasis Valve Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 28 North America Hemostasis Valve Market Outlook, By End User (2020-2028) ($MN)
  • Table 29 North America Hemostasis Valve Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 30 North America Hemostasis Valve Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 31 North America Hemostasis Valve Market Outlook, By Specialty Clinics (2020-2028) ($MN)
  • Table 32 North America Hemostasis Valve Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 33 Europe Hemostasis Valve Market Outlook, By Country (2020-2028) ($MN)
  • Table 34 Europe Hemostasis Valve Market Outlook, By Type (2020-2028) ($MN)
  • Table 35 Europe Hemostasis Valve Market Outlook, By One-handed Hemostasis Valves (2020-2028) ($MN)
  • Table 36 Europe Hemostasis Valve Market Outlook, By Double Y-connector Hemostasis Valves (2020-2028) ($MN)
  • Table 37 Europe Hemostasis Valve Market Outlook, By Hemostasis Valve Y-connectors (2020-2028) ($MN)
  • Table 38 Europe Hemostasis Valve Market Outlook, By Other Types (2020-2028) ($MN)
  • Table 39 Europe Hemostasis Valve Market Outlook, By Application (2020-2028) ($MN)
  • Table 40 Europe Hemostasis Valve Market Outlook, By Angioplasty (2020-2028) ($MN)
  • Table 41 Europe Hemostasis Valve Market Outlook, By Angiography (2020-2028) ($MN)
  • Table 42 Europe Hemostasis Valve Market Outlook, By Interventional Cardiology & Radiology (2020-2028) ($MN)
  • Table 43 Europe Hemostasis Valve Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 44 Europe Hemostasis Valve Market Outlook, By End User (2020-2028) ($MN)
  • Table 45 Europe Hemostasis Valve Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 46 Europe Hemostasis Valve Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 47 Europe Hemostasis Valve Market Outlook, By Specialty Clinics (2020-2028) ($MN)
  • Table 48 Europe Hemostasis Valve Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 49 Asia Pacific Hemostasis Valve Market Outlook, By Country (2020-2028) ($MN)
  • Table 50 Asia Pacific Hemostasis Valve Market Outlook, By Type (2020-2028) ($MN)
  • Table 51 Asia Pacific Hemostasis Valve Market Outlook, By One-handed Hemostasis Valves (2020-2028) ($MN)
  • Table 52 Asia Pacific Hemostasis Valve Market Outlook, By Double Y-connector Hemostasis Valves (2020-2028) ($MN)
  • Table 53 Asia Pacific Hemostasis Valve Market Outlook, By Hemostasis Valve Y-connectors (2020-2028) ($MN)
  • Table 54 Asia Pacific Hemostasis Valve Market Outlook, By Other Types (2020-2028) ($MN)
  • Table 55 Asia Pacific Hemostasis Valve Market Outlook, By Application (2020-2028) ($MN)
  • Table 56 Asia Pacific Hemostasis Valve Market Outlook, By Angioplasty (2020-2028) ($MN)
  • Table 57 Asia Pacific Hemostasis Valve Market Outlook, By Angiography (2020-2028) ($MN)
  • Table 58 Asia Pacific Hemostasis Valve Market Outlook, By Interventional Cardiology & Radiology (2020-2028) ($MN)
  • Table 59 Asia Pacific Hemostasis Valve Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 60 Asia Pacific Hemostasis Valve Market Outlook, By End User (2020-2028) ($MN)
  • Table 61 Asia Pacific Hemostasis Valve Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 62 Asia Pacific Hemostasis Valve Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 63 Asia Pacific Hemostasis Valve Market Outlook, By Specialty Clinics (2020-2028) ($MN)
  • Table 64 Asia Pacific Hemostasis Valve Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 65 South America Hemostasis Valve Market Outlook, By Country (2020-2028) ($MN)
  • Table 66 South America Hemostasis Valve Market Outlook, By Type (2020-2028) ($MN)
  • Table 67 South America Hemostasis Valve Market Outlook, By One-handed Hemostasis Valves (2020-2028) ($MN)
  • Table 68 South America Hemostasis Valve Market Outlook, By Double Y-connector Hemostasis Valves (2020-2028) ($MN)
  • Table 69 South America Hemostasis Valve Market Outlook, By Hemostasis Valve Y-connectors (2020-2028) ($MN)
  • Table 70 South America Hemostasis Valve Market Outlook, By Other Types (2020-2028) ($MN)
  • Table 71 South America Hemostasis Valve Market Outlook, By Application (2020-2028) ($MN)
  • Table 72 South America Hemostasis Valve Market Outlook, By Angioplasty (2020-2028) ($MN)
  • Table 73 South America Hemostasis Valve Market Outlook, By Angiography (2020-2028) ($MN)
  • Table 74 South America Hemostasis Valve Market Outlook, By Interventional Cardiology & Radiology (2020-2028) ($MN)
  • Table 75 South America Hemostasis Valve Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 76 South America Hemostasis Valve Market Outlook, By End User (2020-2028) ($MN)
  • Table 77 South America Hemostasis Valve Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 78 South America Hemostasis Valve Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 79 South America Hemostasis Valve Market Outlook, By Specialty Clinics (2020-2028) ($MN)
  • Table 80 South America Hemostasis Valve Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 81 Middle East & Africa Hemostasis Valve Market Outlook, By Country (2020-2028) ($MN)
  • Table 82 Middle East & Africa Hemostasis Valve Market Outlook, By Type (2020-2028) ($MN)
  • Table 83 Middle East & Africa Hemostasis Valve Market Outlook, By One-handed Hemostasis Valves (2020-2028) ($MN)
  • Table 84 Middle East & Africa Hemostasis Valve Market Outlook, By Double Y-connector Hemostasis Valves (2020-2028) ($MN)
  • Table 85 Middle East & Africa Hemostasis Valve Market Outlook, By Hemostasis Valve Y-connectors (2020-2028) ($MN)
  • Table 86 Middle East & Africa Hemostasis Valve Market Outlook, By Other Types (2020-2028) ($MN)
  • Table 87 Middle East & Africa Hemostasis Valve Market Outlook, By Application (2020-2028) ($MN)
  • Table 88 Middle East & Africa Hemostasis Valve Market Outlook, By Angioplasty (2020-2028) ($MN)
  • Table 89 Middle East & Africa Hemostasis Valve Market Outlook, By Angiography (2020-2028) ($MN)
  • Table 90 Middle East & Africa Hemostasis Valve Market Outlook, By Interventional Cardiology & Radiology (2020-2028) ($MN)
  • Table 91 Middle East & Africa Hemostasis Valve Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 92 Middle East & Africa Hemostasis Valve Market Outlook, By End User (2020-2028) ($MN)
  • Table 93 Middle East & Africa Hemostasis Valve Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 94 Middle East & Africa Hemostasis Valve Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
  • Table 95 Middle East & Africa Hemostasis Valve Market Outlook, By Specialty Clinics (2020-2028) ($MN)
  • Table 96 Middle East & Africa Hemostasis Valve Market Outlook, By Other End Users (2020-2028) ($MN)